Anúncio
Anúncio

TGTX

TGTX logo

TG Therapeutics, Inc.

30.50
USD
Patrocinado
+0.16
+0.54%
08 de jan., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

30.49

-0.02
-0.05%

Relatórios de Lucros TGTX

Rácio de surpresa positiva

TGTX separação 12 de 40 últimas estimativas.

30%

Próximo Relatório

Data do Próximo Relatório
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q-- -1 (Revenue/ EPS)
--
/
--

TG Therapeutics, Inc. earnings per share and revenue

On 03 de nov. de 2025, TGTX reported earnings of 0.16 USD per share (EPS) for Q3 25, missing the estimate of 0.22 USD, resulting in a -28.70% surprise. Revenue reached 161.71 milhão, compared to an expected 155.21 milhão, with a 4.19% difference. The market reacted with a -3.13% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analistas forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, TG Therapeutics, Inc. reported EPS of $0.16, missing estimates by -28.7%, and revenue of $161.71M, 4.19% above expectations.
The stock price moved down -3.13%, changed from $34.78 before the earnings release to $33.69 the day after.
The next earning report is scheduled for --.
Based on -- analistas, TG Therapeutics, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio